EFM
CERE
E Fund Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,132
| Closed | -$455K | – | 375 |
|
|
2024
Q2 | $455K | Buy |
11,132
+626
| +6% | +$25.6K | 0.03% | 186 |
|
|
2024
Q1 | $444K | Buy |
10,506
+2,907
| +38% | +$123K | 0.03% | 179 |
|
|
2023
Q4 | $322K | Sell |
7,599
-2,624
| -26% | -$111K | 0.02% | 221 |
|
|
2023
Q3 | $223K | Buy |
10,223
+722
| +8% | +$15.7K | 0.02% | 241 |
|
|
2023
Q2 | $302K | Sell |
9,501
-2,431
| -20% | -$77.3K | 0.02% | 216 |
|
|
2023
Q1 | $291K | Sell |
11,932
-577
| -5% | -$14.1K | 0.02% | 230 |
|
|
2022
Q4 | $395K | Buy |
12,509
+2,109
| +20% | +$66.6K | 0.03% | 182 |
|
|
2022
Q3 | $294K | Buy |
10,400
+1,916
| +23% | +$54.2K | 0.03% | 242 |
|
|
2022
Q2 | $224K | Buy |
+8,484
| New | +$224K | 0.02% | 281 |
|